{"product_id":"neurontin-gabapentin-300mg-30capsules","title":"NEURONTIN (GABAPENTINA) 300 MG 30 CAPS","description":"\u003cdiv\u003e\n\u003cp data-start=\"0\" data-end=\"34\"\u003e\u003cstrong data-start=\"0\" data-end=\"34\"\u003eNEURONTIN (GABAPENTINA) 300 mg\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp data-start=\"36\" data-end=\"198\"\u003eComparable a: Neurontin\u003cbr data-start=\"59\" data-end=\"62\"\u003eSustancia activa: Gabapentina\u003cbr data-start=\"91\" data-end=\"94\"\u003eConcentración: 300 mg por cápsula\u003cbr data-start=\"127\" data-end=\"130\"\u003ePresentación: Caja con 30 cápsulas\u003cbr data-start=\"164\" data-end=\"167\" data-is-only-node=\"\"\u003eLaboratorio: PFIZER\u003cbr data-start=\"179\" data-end=\"182\"\u003eOrigen: México\u003c\/p\u003e\n\u003cp data-start=\"200\" data-end=\"587\"\u003eNeurontin es un medicamento anticonvulsivo y neuromodulador utilizado para el tratamiento de \u003cstrong data-start=\"293\" data-end=\"306\"\u003eepilepsia\u003c\/strong\u003e (como terapia adyuvante) y \u003cstrong data-start=\"334\" data-end=\"355\"\u003edolor neuropático\u003c\/strong\u003e (como neuropatía diabética o neuralgia posherpética). La gabapentina actúa modulando la actividad de los neurotransmisores en el sistema nervioso central para ayudar a reducir las convulsiones y aliviar el dolor de origen nervioso.\u003c\/p\u003e\n\u003cp data-start=\"589\" data-end=\"738\"\u003eEl consumo de este producto es responsabilidad de quien lo recomienda y quien lo usa. Consulte a su médico antes de consumir cualquier medicamento.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv style=\"position: absolute; display: block; left: -1000px; top: 0px; width: 1px; height: 1px; overflow-x: hidden; overflow-y: hidden;\" id=\"__shopify_paste\"\u003e\n\u003cdiv style=\"font-family: arial; font-size: 12px; zoom: 1;\" dir=\"ltr\"\u003e\u003cspan id=\"result_box\" lang=\"en\" class=\"long_text\"\u003e\u003cspan title=\"\"\u003eTHERAPEUTIC INDICATIONS:\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eAnticonvulsant:\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eEpilepsy: Gabapentin is indicated as monotherapy for partial seizures, with or without secondary generalization in adults and children over 12 years.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eGabapentin is indicated as adjunctive therapy in the treatment of partial seizures with or without secondary generalization in adults and children over 3 years.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eNeuropathic Pain: Gabapentin is indicated for the treatment of neuropathic pain in patients 18 years of age and older.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eContraindications Gabapentin is contraindicated in patients who have shown hypersensitivity to gabapentin or ingredients.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eCAUTIONS:\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eGeneral: Although there is no evidence of rebound seizures with gabapentin, the sudden interruption in the administration of anticonvulsant drugs in epileptic patients may cause status epilepticus (see DOSAGE AND ADMINISTRATION.)\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eIn general, gabapentin is not considered to be useful for the treatment of absence seizures.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003ePatients who received concomitant treatment with morphine may experience increases in the concentration of gabapentin. \u003c\/span\u003e\u003cspan title=\"\"\u003ePatients should be watched carefully because of signs of central nervous system depression, drowsiness, and the dose of gabapentin or morphine should be reduced appropriately.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eEffects on ability to drive motor vehicles or use machines Patients should be advised not to drive or use potentially dangerous machinery until you know if this medication does not affect your ability to perform these activities.\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eRESTRICTIONS OF USE DURING PREGNANCY AND LACTATION:\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan style=\"background-color: #e6ecf9;\" title=\"\"\u003ePregnancy: There have been no adequate and well controlled studies in pregnant women. \u003c\/span\u003e\u003cspan title=\"\"\u003eTherefore, this drug should only be used during pregnancy if the potential benefit to the patient justifies the potential risk to the fetus (see PRECAUTIONS in relation to terms of carcinogenicity, mutagenicity, teratogenicity and fertility, teratogenesis).\u003cbr\u003e\u003cbr\u003e\u003c\/span\u003e\u003cspan title=\"\"\u003eBreast-feeding: Gabapentin is excreted in human milk. \u003c\/span\u003e\u003cspan title=\"\"\u003eDue to the unknown effect on the infant, caution should be exercised when gabapentin is administered to mothers during lactation. \u003c\/span\u003e\u003cspan title=\"\"\u003eGabapentin should only be used in nursing mothers when the benefits to the mother clearly outweigh the risks to the child.\u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003cdiv style=\"font-family: arial; font-size: 12px; zoom: 1;\" dir=\"ltr\"\u003e\u003cspan lang=\"en\" class=\"long_text\"\u003e\u003cspan title=\"\"\u003e\u003cbr\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003cdiv style=\"font-family: arial; font-size: 12px; zoom: 1;\" dir=\"ltr\"\u003e\n\u003cdiv style=\"border-left-color: #f5f5f5; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: #f5f5f5;\" id=\"gt-res-wrap\"\u003e\n\u003cdiv class=\"almost_half_cell\" id=\"gt-res-content\"\u003e\n\u003cdiv style=\"zoom: 1;\" dir=\"ltr\"\u003e\u003cspan style=\"font-size: 16px; color: #333333; min-height: 93px; display: block; padding: 8px;\" lang=\"en\" class=\"long_text\" id=\"result_box\"\u003e\u003cspan class=\"hps\"\u003eDOSAGE AND\u003c\/span\u003e \u003cspan class=\"hps\"\u003eADMINISTRATION:\u003c\/span\u003e \u003cspan class=\"hps\"\u003eBAPEX\u003c\/span\u003e \u003cspan class=\"hps\"\u003eis administered\u003c\/span\u003e \u003cspan class=\"hps\"\u003eorally,\u003c\/span\u003e \u003cspan class=\"hps\"\u003ewith or\u003c\/span\u003e \u003cspan class=\"hps\"\u003ewithout food.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eThe\u003c\/span\u003e\u003cspan class=\"hps\"\u003etitration\u003c\/span\u003e \u003cspan class=\"hps\"\u003eis\u003c\/span\u003e \u003cspan class=\"hps\"\u003ebased on\u003c\/span\u003e \u003cspan class=\"hps\"\u003eclinical response\u003c\/span\u003e \u003cspan class=\"hps\"\u003eand\u003c\/span\u003e \u003cspan class=\"hps\"\u003eplasma concentrations\u003c\/span\u003e\u003cspan\u003e.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eAdults and adolescents\u003c\/span\u003e \u003cspan class=\"hps\"\u003e(\u0026gt;\u003c\/span\u003e \u003cspan class=\"hps\"\u003e12 years\u003c\/span\u003e \u003cspan class=\"hps\"\u003eof age) with\u003c\/span\u003e \u003cspan class=\"hps\"\u003eepilepsy\u003c\/span\u003e\u003cspan\u003e: Start\u003c\/span\u003e \u003cspan class=\"hps\"\u003ewith 300\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg\u003c\/span\u003e \u003cspan class=\"hps\"\u003ethree times daily\u003c\/span\u003e\u003cspan class=\"hps\"\u003e(900\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg\u003c\/span\u003e\u003cspan\u003e) from\u003c\/span\u003e \u003cspan class=\"hps\"\u003ethe first day or\u003c\/span\u003e \u003cspan class=\"hps\"\u003e300 mg\u003c\/span\u003e \u003cspan class=\"hps\"\u003estarting with\u003c\/span\u003e \u003cspan class=\"hps\"\u003ethe 1st\u003c\/span\u003e\u003cspan\u003e.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eday, 600\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg\u003c\/span\u003e \u003cspan class=\"hps\"\u003ethe 2nd.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eday and\u003c\/span\u003e\u003cspan class=\"hps\"\u003eending with\u003c\/span\u003e \u003cspan class=\"hps\"\u003e900 mg\u003c\/span\u003e \u003cspan class=\"hps\"\u003ethe third day.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eThe\u003c\/span\u003e \u003cspan class=\"hps\"\u003edose may be increased\u003c\/span\u003e \u003cspan class=\"hps\"\u003egradually\u003c\/span\u003e \u003cspan class=\"hps\"\u003eaccording to\u003c\/span\u003e \u003cspan class=\"hps\"\u003eclinical response\u003c\/span\u003e\u003cspan\u003e.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eThe maximum interval between\u003c\/span\u003e \u003cspan class=\"hps\"\u003edoses should not\u003c\/span\u003e \u003cspan class=\"hps\"\u003eexceed 12 hours.\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eBAPEX\u003c\/span\u003e \u003cspan class=\"hps\"\u003edose\u003c\/span\u003e \u003cspan class=\"hps\"\u003ein pediatric patients\u003c\/span\u003e \u003cspan class=\"hps\"\u003e3 to\u003c\/span\u003e \u003cspan class=\"hps\"\u003e12 years\u003c\/span\u003e\u003cspan\u003e,\u003c\/span\u003e \u003cspan class=\"hps\"\u003ewill\u003c\/span\u003e \u003cspan class=\"hps\"\u003ebe initially\u003c\/span\u003e \u003cspan class=\"hps\"\u003e10 to 15\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg\u003c\/span\u003e \u003cspan class=\"hps\"\u003e\/ kg\u003c\/span\u003e \u003cspan class=\"hps\"\u003e\/ day in\u003c\/span\u003e\u003cspan class=\"hps\"\u003eequally\u003c\/span\u003e \u003cspan class=\"hps\"\u003edivided doses\u003c\/span\u003e \u003cspan class=\"hps\"\u003e(three\u003c\/span\u003e \u003cspan class=\"hps\"\u003etimes a\u003c\/span\u003e \u003cspan class=\"hps\"\u003eday).\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eThe effective dose\u003c\/span\u003e \u003cspan class=\"hps\"\u003ein pediatric patients aged\u003c\/span\u003e \u003cspan class=\"hps\"\u003e5 years\u003c\/span\u003e \u003cspan class=\"hps\"\u003eand older\u003c\/span\u003e \u003cspan class=\"hps\"\u003eafter three\u003c\/span\u003e \u003cspan class=\"hps\"\u003edays of\u003c\/span\u003e \u003cspan class=\"hps\"\u003egraduation\u003c\/span\u003e\u003cspan class=\"hps\"\u003eis 25 to\u003c\/span\u003e \u003cspan class=\"hps\"\u003e35 mg\u003c\/span\u003e \u003cspan class=\"hps\"\u003e\/ kg\u003c\/span\u003e \u003cspan class=\"hps\"\u003e\/ day in\u003c\/span\u003e \u003cspan class=\"hps\"\u003eequally\u003c\/span\u003e \u003cspan class=\"hps\"\u003edivided doses\u003c\/span\u003e \u003cspan class=\"hps\"\u003e(three\u003c\/span\u003e \u003cspan class=\"hps\"\u003etimes a\u003c\/span\u003e \u003cspan class=\"hps\"\u003eday) and\u003c\/span\u003e \u003cspan class=\"hps\"\u003epatients 3 to\u003c\/span\u003e \u003cspan class=\"hps\"\u003e5 years\u003c\/span\u003e \u003cspan class=\"hps\"\u003eis 40\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg \/\u003c\/span\u003e \u003cspan class=\"hps\"\u003ekg\u003c\/span\u003e \u003cspan class=\"hps\"\u003e\/ day in\u003c\/span\u003e \u003cspan class=\"hps\"\u003eequally\u003c\/span\u003e \u003cspan class=\"hps\"\u003edivided doses\u003c\/span\u003e \u003cspan class=\"hps\"\u003e(three\u003c\/span\u003e \u003cspan class=\"hps\"\u003etimes a\u003c\/span\u003e \u003cspan class=\"hps\"\u003eday).\u003c\/span\u003e\u003cbr\u003e\u003cbr\u003e\u003cspan class=\"hps\"\u003eFor adult patients\u003c\/span\u003e \u003cspan class=\"hps\"\u003ewith neuropathic pain\u003c\/span\u003e\u003cspan\u003e, start\u003c\/span\u003e \u003cspan class=\"hps\"\u003ewith 900\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg\u003c\/span\u003e \u003cspan class=\"hps\"\u003e\/ day in\u003c\/span\u003e \u003cspan class=\"hps\"\u003ethree doses.\u003c\/span\u003e \u003cspan class=\"hps\"\u003eAdjust the dose\u003c\/span\u003e \u003cspan class=\"hps\"\u003eaccording to response\u003c\/span\u003e\u003cspan\u003e, not to exceed\u003c\/span\u003e \u003cspan class=\"hps\"\u003e3.600\u003c\/span\u003e \u003cspan class=\"hps\"\u003emg\u003c\/span\u003e \u003cspan class=\"hps\"\u003e\/ day.\u003c\/span\u003e\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PFIZER","offers":[{"title":"Default Title","offer_id":170469482,"sku":"FDN-00101","price":1378.47,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0111\/7372\/products\/MEDXPHARMA_43.jpg?v=1652119951","url":"https:\/\/www.farmaciasdelnino.com.mx\/products\/neurontin-gabapentin-300mg-30capsules","provider":"FARMACIA DEL NIÑO","version":"1.0","type":"link"}